Industries > Pharma > Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030

Back to Pharma Reports

Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030

Forecasts & Analysis by Service, by Application, by End-User Including Forecasts by Major Regions and Countries, Plus Profiles of Leading Companies in the Market

PUBLISHED: 12 February 2020

PAGES: 215

PRODUCT CODE: PHA0672

SUBMARKET: Contract Services

Licence

Clear

DOWNLOAD FREE SAMPLE

SKU: PHA0672 Categories: Contract Services, Pharma Tags: MAT0165, PHA0407, PHA0519, PHA0629, PHA0672, PHA0718, PHA0729, PHA0790, PHA1018, PHA1026, PHA1137, PHA1178

The new report from business intelligence provider Visiongain offers an updated outlook for the global clinical research organizations (CROs) market. Visiongain assesses that the clinical research organizations (CROs) market will generate revenues of $38.0 billion in 2020. Contract research organizations (CROs) have become essential to pharmaceutical, biotech and other medical-related industries by supporting their clients’ efforts to test, refine and market the latest pharmaceuticals and medical devices through clinical trials.

The global CRO market value has grown by nearly a 9.5% compound annual growth rate (CAGR) over the past several years and is expected to reach $38 billion in 2020 and $94 billion by 2030, as specialized demand, patent expiration and proliferation of generic medications are all leading to greater outsourcing of work to CROs. Also driving the trend toward CRO outsourcing is pharmaceutical companies’ (pharma companies’) increasing need to reduce clinical trial costs and improve efficiencies. This in turn is increasing time-to-market urgencies for pharma companies while also leading to pricing pressures and greater margin awareness. Pharmaceutical companies are focusing on niche sector CROs to expand their knowledgebase in highly complex trial areas, and functional service provider (FSP) contracts are allowing them the ability to outsource individual services rather than entire studies or projects. This integrated Pharma-CRO partnership leads to efficiency gains and is often desirable for studies of high complexity, tight time constraints and/or broader scope.

Strong demand and increased competitiveness are facilitating mergers and partnerships to enhance larger companies’ full-service capabilities and international reach. Recovery of capital markets and strong revenue potential are boosting CRO valuations, which is also increasing merger and acquisition (M&A) activity and public offerings in the industry.

CROs are benefiting from top-line growth among deep-pocketed pharmaceutical companies in addition to several drivers specific to current industry trends. Pharmaceutical companies are bringing a record number of drugs to market in a more time-sensitive and competitive environment. As acceleration of time-to-market and increased cost-effectiveness have become critical, CROs are capitalizing on their expertise in specific areas of the clinical research process.

Pharma pipelines are currently ripe with new-age, complex therapies that are nearing market readiness. Regenerative cell-based therapies, chimeric antigen receptor (CAR)-modified T cell therapy (CAR-T), immune-oncology combinations and innovative autoimmune therapies are just some of the new fields being studied in clinical trials across the globe. More adept use of data and analytics by pharma and CROs is leading to more appropriate patient trial selection and more adaptive trial designs. Adaptive design studies, risk-based monitoring and other flexible approaches can reduce costs while allowing adaptions as studies progress. These trends mitigate risks for pharma companies and patient pools while facilitating the pursuit of more potential therapies and enhancing the drug discovery pipeline. Correspondingly, patient receptiveness is at an all-time high. These factors are all contributing to the rapid proliferation of clinical trials in the U.S. and throughout the globe.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in the clinical research organizations (CROs) sector. Visiongain’s new study tells you and tells you NOW.

In this brand-new report, you will receive 214 in-depth tables, charts and graphs– all unavailable elsewhere.

The 215-page report provides clear detailed insight into the global clinical research organizations (CROs) market. It reveals the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you will be better informed and ready to act.

Report Scope

• Global clinical research organizations (CROs) market forecasts from 2020-2030

• Regional clinical research organizations (CROs) market forecasts from 2020-2030 covering
– North America
– South America
– Western Europe
– Eastern Europe
– Asia-Pacific
– Middle East and Africa

• Country level clinical research organizations (CROs) forecasts from 2020-2030 covering
– US
– Canada
– Mexico
– UK
– Germany
– Japan
– Brazil
– India
– RoW

Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030

• Clinical Research Organizations (CROs) submarket forecasts from 2020-2030 covering services
– Drug Discovery
– Pre-Clinical & Clinical
– Laboratory Services
– Other Service

• Clinical Research Organizations (CROs) submarket forecasts from 2020-2030 covering Application
– Cardiology
– Infectious Disease
– Oncology
– Metabolic Disorders
– Other Applications

• Clinical Research Organizations (CROs) submarket forecasts from 2020-2030 covering End-Users
– Pharmaceutical & Biotechnological Companies
– Academic & Research Institutes

• Analysis of the key factors driving growth in the global, regional and country level clinical research organizations (CROs) markets from 2020-2030

Profiles and competitive positioning map of the leading 10 clinical research organizations (CROs) companies
• Charles River Laboratories
• Frontage Laboratories, Inc.,
• Icon Plc
• Syneos Health, Inc. (Inc Research/Inventive Health)
• LabCorp/Covance
• Parexel
• Pharmaceutical Product Development
• PRA Health Services
• Quintiles
• WuXiAppTec

How will you benefit from this report?
• This report will keep your clinical research organizations (CROs) knowledge base up to speed. Don’t get left behind
• This report will reinforce strategic decision decision-making based upon definitive and reliable market data
• You will learn how to exploit new clinical research organizations (CROs) technological trends
• You will be able to realise your company’s full potential within the market
• You will better understand the competitive landscape and identify potential new business opportunities & partnerships

Who should read this report?
• Anyone within the pharma & value chain
• Investment analysts
• Investment consultancies
• CEO’s
• COO’s
• CIO’s
• Business development managers
• Marketing managers

Visiongain’s study is intended for anyone requiring commercial analyses for the clinical research organizations (CROs) market and leading companies. You will find data, trends and predictions.

Buy our report today Global Contract Research Organisations (CROs) Market: Forecasts & Analysis by Service, by Application, by End-User Including Forecasts by Major Regions and Countries, Plus Profiles of Leading Companies in the Market. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

1. REPORT OVERVIEW

1.1 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CRO) MARKET OVERVIEW

1.1.1 Pharma-CRO Relationships

1.2 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CRO) MARKET SEGMENTATION

1.3 MARKET DEFINITION

1.4 HOW THIS REPORT DELIVERS

1.5 KEY QUESTIONS ANSWERED BY THIS ANALYTICAL REPORT INCLUDE:

1.6 WHY YOU SHOULD READ THIS REPORT?

1.7 WHO IS THIS REPORT FOR?

1.8 METHODOLOGY

1.9 FREQUENTLY ASKED QUESTIONS (FAQ)

1.10 ASSOCIATED VISIONGAIN REPORTS

1.11 ABOUT VISIONGAIN

2. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CRO) MARKET

2.1. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE AND FORECAST (2020-2030)

2.2. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET BY SERVICE

2.3. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET BY APPLICATION

2.3.1 Oncology

2.3.2 Infectious Diseases

2.3.3 Metabolic Disorders

2.3.4 Cardiology

2.4. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET BY END-USER

2.4.1 PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES

2.4.2 ACADEMIC RESEARCH ORGANIZATION (ARO)

2.5. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET BY REGION

3. CLINICAL TRIAL PROCESS AND CRO FUNCTIONAL SERVICES-AN OVERVIEW

3.1 INTRODUCTION

3.2 CLINICAL TRIAL PROCESS AND STAGES

3.2.1 Pre-discovery

3.2.2 Drug Discovery

3.2.3 Preclinical

3.2.4 Clinical

3.3 PHASE I

3.4 PHASE II

3.5 PHASE III

3.6 POST-MARKETING SURVEILLANCE AND PHASE IV STUDIES

3.7 REGULATORY ENVIRONMENT

3.7.1 FDA REGULATION AND IMPACT

3.7.2 The Declaration of Helsinki

3.7.3 CDISC Standards

4. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET TRENDS

4.1 INCREASING COMPLEXITY OF CLINICAL TRIALS

4.2 SMALL AND MID-SIZED BIOPHARMA INNOVATION

4.2.1 Small Molecule Versus Biologics

4.3 BIOSIMILARS

4.4 ADAPTIVE TRIAL DESIGN

4.5 RISK-BASED MONITORING

4.6 REAL WORLD EVIDENCE

4.7 REPURPOSING EXISTING DRUGS FOR NEW INDICATIONS

4.8 INCREASED COMPETITION THROUGH THE RESURGENCE OF THE GENERIC DRUG MARKET

4.9 SWOT ANALYSIS OF GLOBAL CLINICAL RESEARCH ORGANIZATIONS

5. NORTH AMERICA MARKET FOR CONTRACT RESEARCH ORGANIZATION

5.1 NORTH AMERICA CRO MARKET BY SERVICE

5.2 NORTH AMERICA CRO MARKET BY APPLICATION

5.3 NORTH AMERICA CRO MARKET BY END USERS

5.4 NORTH AMERICA CRO MARKET BY, COUNTRY

5.4.1 United States of America

5.4.2 Canada

5.4.3 Mexico

6. EUROPE MARKET FOR CONTRACT RESEARCH ORGANISATION

6.1 EUROPE CRO MARKET BY SERVICE

6.2 EUROPE CRO MARKET BY APPLICATIONS

6.3 EUROPE CRO BY END USERS

6.4 EUROPE CRO BY COUNTRY

6.4.1 Germany

6.4.2 United Kingdom

6.4.3 France

6.4.4 Spain

6.4.5 Italy

7. ASIA-PACIFIC MARKET FOR CONTRACT RESEARCH ORGANISATION

7.1 ASIA-PACIFIC CRO MARKET BY SERVICE

7.2 ASIA-PACIFIC CRO BY APPLICATION

7.3 ASIA-PACIFIC CRO BY END USER

7.4 ASIA-PACIFIC CRO MARKET BY COUNTRY

7.4.1 China

7.4.2 India

7.4.3 Japan

7.4.4 Australia

8. REST OF WORLD MARKET FOR CONTRACT RESEARCH ORGANISATION

8.1 REST OF WORLD CRO BY SERVICE

8.2 REST OF WORLD CRO BY APPLICATIONS

8.3 REST OF WORLD CRO BY END USERS

8.4 REST OF WORLD CRO BY COUNTRY

8.4.1 South Africa

8.4.2 Brazil

9. COMPETITIVE LANDSCAPE

9.1 FUNCTIONAL SERVICE PROVIDER RELATIONSHIPS

9.2 OFF SHORING

9.3 THERAPEUTIC AREAS IN DRUG DEVELOPMENT

9.4 CURRENT PHARMA-CRO CONTRACTS

9.5 LARGEST THERAPEUTIC AREAS RELY ON KEY CRO EXPERTISE

9.6 MERGERS AND ACQUISITIONS

9.6.1 Recent Merger and Acquisition Activity

9.6.1.1 Charles River Laboratories

10 COMPANY PROFILES

10.1 CHARLES RIVER LABORATORIES

10.1.1 Company Overview

10.1.2 Company Financials

10.1.3 Company Recent Developments

10.2 FRONTAGE LABORATORIES, INC.,

10.2.1 Company Overview

10.2.2 Company Financials

10.2.3 Company Recent Developments

10.3 ICON PLC

10.3.1 Company Overview

10.3.2 Company Products & Services

10.3.3 Company Financials

10.3.4 Company Recent Developments

10.4 SYNEOS HEALTH, INC. (INC RESEARCH/INVENTIVE HEALTH)

10.4.1 Company Overview

10.4.2 Company Financials

10.4.3 Company Recent Developments

10.5 LABCORP/COVANCE

10.5.1 Company Overview

10.5.2 Company Financials

10.5.3 Company Recent Developments

10.6PAREXEL

10.6.1 Company Overview

10.6.2 Company Products & Services

10.6.3 Company Financials

10.7 PHARMACEUTICAL PRODUCT DEVELOPMENT

10.7.1 Company Overview

10.7.2 Company Products & Services

10.7.3 Company Recent Developments

10.8 PRA HEALTH SERVICES

10.8.1 Company Overview

10.8.2 Company Products & Services

10.8.3 Company Financials

10.8.4 Company Recent Developments

10.9 QUINTILES

10.9.1 Company Overview

10.9.2 Company Financials

10.9.3 Company Recent Developments

10.10 WUXIAPPTEC

10.10.1 Company Overview

10.10.2 Company Products & Services

10.10.3 Company Financials

10.10.4 Company Recent Developments

11.CONCLUSION

12. GLOSSARY

12.1 TECHNICAL DEFINITIONS

ASSOCIATED VISIONGAIN REPORTS

VISIONGAIN REPORT SALES ORDER FORM

APPENDIX A

ABOUT VISIONGAIN

APPENDIX B

VISIONGAIN REPORT EVALUATION FORM

List of Tables

Table 2.1 Global Contract Research Organizations Market, 2020-2030 (US$ Billion)

Table 2.2 Global Contract Research Organizations Market by Service, 2020-2030 (US$ Billion)

Table 2.3 Global Contract Research Organizations Market by End-Use, 2020-2030 (US$ Billion)

Table 2.4 Global Contract Research Organizations Market by Application, 2020-2030 (US$ Billion)

Table 2.5 Global Contract Research Organizations Market by Region, 2020-2030 (US$ Billion)

Table 3.1 Likelihood of Approval, by Major Disease Area/Phase (%)

Table 3.2 Clinical Phase Description

Table 3.3 New Drug Approvals: New Drugs Entering the Market at an Increasing Pace Until Last Year, 2006–2018

Table 5.1 North America Contract Research Organizations Market by Service, 2020-2030 (US$ Billion)

Table 5.2 North America Contract Research Organizations Market by End-Use, 2020-2030 (US$ Billion)

Table 5.3 North America Contract Research Organizations Market by Application, 2020-2030 (US$ Billion)

Table 5.4 North America Contract Research Organizations Market by Country, 2020-2030 (US$ Billion)

Table 5.5 List of Contract Research Organizations in U.S.

Table 5.6 List of Contract Research Organizations in Canada

Table 5.7 List of Contract Research Organizations in Mexico

Table 6.1 Europe Contract Research Organizations Market by Service, 2020-2030 (US$ Billion)

Table 6.2 Europe Contract Research Organizations Market by End-Use, 2020-2030 (US$ Billion)

Table 6.3 Europe Contract Research Organizations Market by Application, 2020-2030 (US$ Billion)

Table 6.4 Europe Contract Research Organizations Market by Country, 2020-2030 (US$ Billion)

Table 6.5 List of Contract Research Organizations in Germany

Table 6.6 List of Contract Research Organizations in the U.K.

Table 6.7 List of Contract Research Organizations in France

Table 6.8 List of Contract Research Organizations in Spain

Table 6.9 List of Contract Research Organizations in Italy

Table 7.1 Asia-Pacific Contract Research Organizations Market by Service, 2020-2030 (US$ Billion)

Table 7.2 Asia-Pacific Contract Research Organizations Market by End-Use, 2020-2030 (US$ Billion)

Table 7.3 Asia-Pacific Contract Research Organizations Market by Application, 2020-2030 (US$ Billion)

Table 7.4 Asia-Pacific Contract Research Organizations Market by Country, 2020-2030 (US$ Billion)

Table 7.5 List of Contract Research Organizations in China

Table 7.6 List of Contract Research Organizations in India

Table 7.7 List of Contract Research Organizations in Japan

Table 7.8 List of Contract Research Organizations in Australia

Table 7.9 RoW Contract Research Organizations Market by Service, 2020-2030 (US$ Billion)

Table 7.10 RoW Contract Research Organizations Market by End-Use, 2020-2030 (US$ Billion)

Table 8.1 RoW Contract Research Organizations Market by Application, 2020-2030 (US$ Billion)

Table 8.2 RoW Contract Research Organizations Market by Country, 2020-2030 (US$ Billion)

Table 8.3 List of Contract Research Organizations in South Africa

Table 8.4 List of Contract Research Organizations in Brazil

Table 9.1 Comparative View of Services Provided by CRO Companies

Table 9.2 Key Players in Therapeutic Areas

Table 9.3 Strategic alliances, CROs and pharma/CRO alliances are shaping future landscape.

Table 9.4 M &A Activity Among Pharma/CROs: Recent M &A Deals in Pharma Outsourcing Sector ($ Millions)

Table 9.5 Deal Types in CRO Sector: Improving Capital Markets Leading to More IPOs ($ Millions)

Table 10.1 Charles River Laboratories Company Details

Table 10.2 Charles River Laboratories Product and Service Offerings

Table 10.3 Charles River Laboratories Recent Developments

Table 10.4 Frontage Laboratories, Inc., Company Details

Table 10.5 Frontage Laboratories, Inc., Services

Table 10.6 Frontage Laboratories, Inc., Company Recent Developments

Table 10.7 Icon Plc Company Details

Table 10.8 ICON Product and Service Offerings

Table 10.9 ICON Company Recent Developments

Table 10.10 Syneos Health, Inc. Company Details

Table 10.11 Syneos Health, Inc. Company Recent Developments

Table 10.12 LabCorp/Covance Company Details

Table 10.13 LabCorp/Covance Company Recent Developments

Table 10.14 Parexel Company Details

Table 10.15 Parexel Product and Service Offerings

Table 10.16 Pharmaceutical Product Development Company Details

Table 10.17 Pharmaceutical Product Development Product and Service Offerings

Table 10.18 Pharmaceutical Product Development Company Recent Developments

Table 10.19 PRA Health Services Company Details

Table 10.20 PRA Health Services Product and Service Offerings

Table 10.21 PRA Health Services Company Recent Developments

Table 10.22 Quintiles Company Details

Table 10.23 Quintiles Product and Service Offerings

Table 10.24 WuXiAppTec Company Details

Table 10.25 WuXiAppTec Product and Service Offerings

Table 10.26 WuXiAppTec Company Recent Developments

List of Figures

Figure 1.1 Total Number of Registered Clinical Studies Worldwide, 2000-2019

Figure 1.2 Global Contract Research Organizations (CRO) Market Segmentation

Figure 2.1 Global Contract Research Organizations Market, 2020-2030 (US$ Billion)

Figure 2.2 Global Contract Research Organizations Market by Service, 2020-2030 (US$ Billion)

Figure 2.3 Global Contract Research Organizations Market by End-Use, 2020-2030 (US$ Billion)

Figure 2.4 Global Contract Research Organizations Market by Application, 2020-2030 (US$ Billion)

Figure 2.5 Global Contract Research Organizations Market by Region, 2020-2030 (US$ Billion)

Figure 3.1 Stages of Clinical Developments

Figure 3.2 Drug Approval Timeline

Figure 4.1 Total Number of Trial Registrations by WHO, Region, 1999-2018

Figure 5.1 Contract Research Organization Map in U.S. ( 8887 Labs)

Figure 5.2 Contract Research Organization Map in Canada (663 Labs)

Figure 5.3 Contract Research Organization Map in Mexico (29 Labs)

Figure 6.1 Contract Research Organization Map in Germany ( 1050 Labs)

Figure 6.2 Contract Research Organization Map in the U.K. ( 1378 Labs)

Figure 6.3 Contract Research Organization Map in France ( 534 Labs)

Figure 6.4 Contract Research Organization Map in Spain (237 Labs)

Figure 6.5 Contract Research Organization Map in Italy (284 Labs)

Figure 7.1 Contract Research Organization Map in China (653 Labs)

Figure 7.2 Contract Research Organization Map in India (589 Labs)

Figure 7.3 Contract Research Organization Map in Japan (279 Labs)

Figure 7.4 Contract Research Organization Map in Australia (254 Labs)

Figure 8.1 Contract Research Organization Map in South Africa ( 53 Labs)

Figure 8.2 Contract Research Organization Map in Brazil (45 Labs)

Figure 9.1 Global CRO Competitor Market Share, by Company, 2019

Figure 9.2 Leading CROs’ Preclinical CRO Market Share, by Company, 2019

Figure 10.1 Charles River Laboratories Total Revenue 2016-2018

Figure 10.2 Charles River Laboratories EBITA 2016-2018

Figure 10.3 Charles River Laboratories Net Income 2016-2018

Figure 10.4 Frontage Laboratories, Inc. Total Revenue 2016-2018

Figure 10.5 Frontage Laboratories, Inc. EBITA 2016-2018

Figure 10.6 Frontage Laboratories, Inc. Net Income 2016-2018

Figure 10.7 ICON Company Total Revenue 2016-2018

Figure 10.8 ICON Company Total EBITA 2016-2018

Figure 10.9 ICON Company Net Income 2016-2018

Figure 10.10 Syneos Health, Inc. Total Revenue 2016-2018

Figure 10.11 Syneos Health, Inc. EBITA 2016-2018

Figure 10.12 Syneos Health, Inc. Net Income 2016-2018

Figure 10.13 LabCorp/Covance Company Total Revenue 2016-2018

Figure 10.14 LabCorp/Covance Company EBITA 2016-2018

Figure 10.15 LabCorp/Covance Company Net Income 2016-2018

Figure 10.16 Parexel Company Total Revenue 2016-2018

Figure 10.17 Parexel Company EBITA 2016-2018

Figure 10.18 Parexel Company Net Income 2016-2018

Figure 10.19 PRA Health Services Company Total Revenue 2016-2018

Figure 10.20 PRA Health Services Company EBITA 2016-2018

Figure 10.21 PRA Health Services Company Net Income 2016-2018

Figure 10.22 Quintiles Company Total Revenue 2016-2018

Figure 10.23 Quintiles Company EBITA 2016-2018

Figure 10.24 Quintiles Company Net Income 2016-2018

Table 10.25 Quintiles Company Recent Developments

Figure 10.26 WuXiAppTec Total Revenue 2016-2018

Figure 10.27 WuXiAppTec EBITA 2016-2018

Figure 10.28 WuXiAppTec Net Income 2016-2018

Companies Profiles

Charles River Laboratories

Frontage Laboratories, Inc.,

Icon Plc

Syneos Health, Inc. (Inc Research/Inventive Health)

LabCorp/Covance

Parexel

Pharmaceutical Product Development

PRA Health Services

Quintiles

WuXiAppTec

Other Companies

4Clinics

Aagami

Absorption Systems

Accelsiors

ACI Clinical

Actimus Bio

Advanced BioScience Laboratories

Advanced Clinical Research Institute

Agilent

Albuquerque Clinical Trials (ACT)

AlcheraBio

Allphase Clinical Research

Amarex Clinical Research

APCER Life Sciences

Applied Healthcare Resource Management (AHRM)

ArisGloba

At Clinical Systems

Avail Clinical Research

Axio Research

AXON

Universal Research Group

BBK

Bio Reliance Corporation

BioFortis

BioRASI Clinical Research

Biotrial

Boston MedTech Advisors

Bradstreet Clinical Research

Burleson Research Technologies (BRT)

Cambridge Biomedical

CATO Research

Celerion

Clinical Research Management Group

Clinical Supplies Management Holdings

Clinipace

A10 Clinical Solutions

ABF Pharmaceutical Services

Accell Clinical Research

Accumedix, Inc

ACM Global Laboratories

Acurian

Advanced Clinical Research (ACR)

Advanced Clinical Services LLC

Akos Urgent Care

Alcami

Alliance for Clinical Trials in Oncology

AlphaGenesis Incorporated (AGI)

Anabase

Applied Biosystems

Aptuit

ARS Clinical Trials

Aurum Clinical Research

Avitacor

AXIS Clinicals

Axon Medchem

BASi

Bio Analytical Research Corporation (BARC)

BioClinica

BioPharma Services Inc

Biostat International

Blue Sky BioServices

Bracket

Bright Pharmaceutical Services

Camargo Pharmaceutical Services

Catalent

CCS Associates

Clinical Research Consulting, Inc.

Clinical Site Services (CSS)

Clinilabs

CliniRx

Advanced Clinical Services LLC

Aptuit

Astron Research

BioClinica

Bracket

Chembiotech Laboratories

Clinlogix

Cmed

CrownBio

Ergomed

hVIVO

OPIS

Pharm-Olam

Pharmalys

Premier Research

Progressive Life Sciences

RenaSci

RTI Health Solutions

Simbec Research

Solicitors Regulation Authority

Synteract

The Clinical Trial Company

Theradex

Venn Life Sciences

ZEINCRO

Applied Healthcare Resource Management (AHRM)

ArisGloba

AXON

Biotrial

Celerion

Clinical Site Services (CSS)

ClinTec International

Congenix

Cyprotex Limited

ERT

MAPI

Orphan Reach

Pharmaceutical Development Services

PharSafer

PrimeVigilance

Quanticate

Richmond Pharmacology

Selcia

Smithers Viscient

Source BioScience Limited

TAKE Solutions

The Smerud Medical Research Group

Transcom Global

Veristat

Download sample pages

Complete the form below to download your free sample pages for Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030

Download sample pages

Complete the form below to download your free sample pages for Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

23 April 2024

READ

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

READ

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

READ

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

READ

Industries > Pharma > Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030

Back to Pharma Reports

Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030

Forecasts & Analysis by Service, by Application, by End-User Including Forecasts by Major Regions and Countries, Plus Profiles of Leading Companies in the Market

Download sample pages

Related reports

Clinical Trial Supply and Logistics Market for Pharma 2019-2029

Thermoformed Plastic Packaging Market Report 2020-2030

eClinical Solution Market Report 2019-2029

Rigid Plastic Packaging Market Report 2020-2030

Pharma Clinical Trial Services Market and Industry Forecast 2020-2030

Cell Therapy Technologies Market Forecast 2020-2030

Clinical Laboratory Tests Market Report 2019-2029

Pharma Leader Series: Top 55 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2020

Global IoT Healthcare Market Forecast 2017-2027

Vaccine Contract Manufacturing Market Forecast 2020-2030

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

Our Clients